AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2014
Oct 7, 2014
30786_dirs_2014-10-07_aa6932cd-3151-4248-9cbd-13f2e199359b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2014-09-29
Reporting Person: Hall Shannon (Executive Vice President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 715.4085 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $0 | Bio-Rad A Common Stock (220) | Direct | ||
| Restricted Stock Units | $0 | Bio-Rad A Common Stock (660) | Direct | ||
| Restricted Stock Units | $0 | Bio-Rad A Common Stock (720) | Direct | ||
| Restricted Stock Units | $0 | Bio-Rad A Common Stock (960) | Direct | ||
| Restricted Stock Units | $0 | Bio-Rad A Common Stock (1200) | Direct |
Footnotes
F1: The restricted stock units vest in five equal annual installments beginning September 8, 2011.
F2: The restricted stock units vest in five equal annual installments beginning November 4, 2012.
F3: The restricted stock units vest in five equal annual installments beginning September 12, 2013.
F4: The restricted stock units vest in five equal annual installments beginning September 11, 2014.
F5: The restricted stock units vest in five equal annual installments beginning September 10, 2015.
F6: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.